Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 332.17%33.27K | -49.60%-71.91K | -54.52%-41.68K | 70.25%-139.08K | 24.74%-49.71K | 87.13%-14.33K | 58.43%-48.07K | 84.54%-26.97K | 6.59%-467.45K | 39.63%-66.04K |
| Net income from continuing operations | -145.47%-48.28K | -217.62%-137.86K | 48.39%-35.55K | 91.57%-175.29K | 76.02%-43.34K | 98.68%-19.67K | 72.33%-43.4K | 72.62%-68.88K | -169.88%-2.08M | -37.88%-180.75K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 1,755.12%1.51M | --89.73K |
| Remuneration paid in stock | --0 | --96K | --0 | -93.15%6.4K | --6.4K | --0 | --0 | --0 | -47.67%93.5K | --0 |
| Change In working capital | 1,026.96%60.15K | -544.15%-30.06K | -114.62%-6.13K | 154.75%29.81K | -151.13%-12.77K | 113.99%5.34K | -111.31%-4.67K | 355.88%41.91K | 12.13%11.7K | 302.64%24.98K |
| -Change in receivables | -60.60%-856 | 326.69%5.56K | -171.02%-4.33K | 224.97%6.19K | 71.35%-679 | -114.38%-533 | 97.88%1.3K | 187.73%6.09K | -119.08%-4.95K | -127.28%-2.37K |
| -Change in prepaid assets | --3.5K | --1.5K | -58.24%2.5K | -128.24%-1.51K | -225.65%-7.5K | --0 | --0 | 22.11%5.99K | 147.25%5.36K | 153.38%5.97K |
| -Change in payables and accrued expense | 267.46%21.57K | 96.24%-1.19K | -114.41%-4.3K | 122.67%25.14K | -0.92%21.01K | 119.75%5.87K | -192.47%-31.58K | 308.09%29.83K | 127.80%11.29K | 337.12%21.21K |
| -Change in other current liabilities | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 332.17%33.27K | -49.60%-71.91K | -54.52%-41.68K | 70.25%-139.08K | 24.93%-49.71K | 87.11%-14.33K | 58.43%-48.07K | 84.54%-26.97K | 6.59%-467.45K | 39.47%-66.21K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,121.28%-177.03K | 56.60%-3.72K | -68.63%-9.21K | 54.46%-71.6K | 72.60%-43.07K | -132.02%-14.5K | 24.64%-8.57K | 83.88%-5.46K | -38.80%-157.22K | -444.23%-157.22K |
| Capital expenditure reported | -1,000.68%-159.54K | ---- | ---- | 54.46%-71.6K | ---43.07K | ---14.5K | ---- | ---- | -2.18%-157.22K | ---- |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | -68.63%-9.21K | ---- | ---- | ---- | ---- | 83.88%-5.46K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,121.28%-177.03K | 56.60%-3.72K | -68.63%-9.21K | 54.46%-71.6K | 53.65%-43.07K | 23.83%-14.5K | 24.64%-8.57K | 83.88%-5.46K | -38.80%-157.22K | -303.46%-92.93K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 204.45K | -73.63%50K | 0 | -43.99%189.6K | 0 | 0 | 189.6K | 0 | 11.43%338.52K | 0 |
| Net common stock issuance | --254.45K | --0 | --0 | -43.99%189.6K | --0 | --0 | --189.6K | --0 | 11.43%338.52K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --204.45K | -73.63%50K | --0 | -43.99%189.6K | --0 | --0 | --189.6K | --0 | 11.43%338.52K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -91.16%19.21K | -46.85%44.84K | -18.04%95.73K | -71.01%116.8K | -31.69%188.51K | 221.32%217.33K | -56.65%84.36K | -71.01%116.8K | -43.47%402.95K | 69.41%275.94K |
| Current changes in cash | 310.56%60.69K | -119.28%-25.63K | -56.90%-50.89K | 92.64%-21.07K | 41.70%-92.78K | -113.84%-28.82K | 204.70%132.97K | 84.43%-32.44K | 7.67%-286.15K | -166.29%-159.14K |
| End cash Position | -57.61%79.9K | -91.16%19.21K | -46.85%44.84K | -18.04%95.73K | -18.04%95.73K | -31.69%188.51K | 221.32%217.33K | -56.65%84.36K | -71.01%116.8K | -71.01%116.8K |
| Free cash from | -338.09%-126.28K | -36.63%-84.84K | -54.52%-41.68K | 66.27%-210.67K | 58.48%-92.78K | 56.28%-28.82K | 61.40%-62.1K | 84.54%-26.97K | 4.53%-624.67K | -114.17%-223.43K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.